The Real Cost of Failed Remote Blood Collections and Why RedDrop Solves It
on November 13, 2025

The Real Cost of Failed Remote Blood Collections and Why RedDrop Solves It

Remote blood collection has become a core feature of telehealth, diagnostics, and decentralized clinical trials. Yet many organizations underestimate the true cost of failed or incomplete samples. Feedback from our customers has shown that devices such as Tasso+ and Tasso M20 and the YourBio TAP II often show higher no analysis rates, which create real operational and financial impacts.

RedDrop was designed to solve this problem at the root.

1. The Hidden Cost of Failed Samples

Incomplete or low volume samples lead to:

  • Customer frustration

  • Repeat testing

  • Higher shipping expense

  • Support team workload

  • Lost revenue

  • Lower lifetime value

Even a small increase in failure rate compounds across thousands of tests each month.

2. Why Some Devices Fail More Often

Tasso+ and Tasso M20 rely on vacuum based flow which can be inconsistent across different skin types, hydration levels, and arm locations. The YourBio TAP II uses microneedles which may produce lower volume output depending on user pressure and hydration. These variables create unpredictable outcomes.

3. How RedDrop Reduces Failure Rates

RedDrop was engineered for consistent and predictable blood flow. Key advantages include:

  • Reliable 1 milliliter volume capacity

  • Simple instructions that reduce user error

  • Stable collection process across skin types

This leads to fewer redraws, fewer customer complaints, and a smoother testing workflow.

4. Better Sample Quality for Labs

Labs need clean, high volume capillary samples to support multi marker panels, automation, and advanced testing. RedDrop enables this with a focus on sample volume and integrity.

5. The Business Impact

More reliable collection directly increases:

  • Revenue

  • Customer satisfaction

  • Testing throughput

  • Partner retention

  • Program scalability

For subscription health platforms, weight loss programs, chronic care services, and trial sponsors, this translates into measurable gains.

Conclusion

The cost of a failed sample is higher than most organizations realize. RedDrop solves this by increasing volume, consistency, and reliability, outperforming Tasso+ and Tasso M20 and the YourBio TAP II in the process.

RedDrop helps partners scale without friction.